| Title: |
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: findings from the LACE sarcopenia trial |
| Authors: |
Shrestha, A; Bashir, T; Achison, M; Adamson, S; Akpan, A; Aspray, T; Avenell, A; Band, MM; Burton, LA; Cvoro, V; Donnan, PT; Duncan, GW; George, J; Gordon, AL; Gregson, CL; Hapca, A; Hume, C; Jackson, TA; Kerr, S; Kilgour, A; Masud, T; McKenzie, A; McKenzie, E; Patel, H; Pilvinyte, K; Roberts, HC; Sayer, AA; Rossios, C; Smith, KT; Soiza, RL; Steves, CJ; Struthers, AD; Tiwari, D; Whitney, J; Witham, MD; Kemp, PR |
| Contributors: |
De Rui, M |
| Publisher Information: |
Public Library of Science (PLoS) |
| Publication Year: |
2024 |
| Collection: |
Imperial College London: Spiral |
| Description: |
Introduction Understanding genetic contributors to sarcopenia (age-related loss of muscle strength and mass) is key to finding effective therapies. Variants of the bradykinin receptor 2 (BDKRB2) have been linked to athletic and muscle performance. The rs1799722–9 and rs5810761 T alleles have been shown to be overrepresented in endurance athletes, possibly due to increased transcriptional rates of the receptor. These variants have been rarely studied in older people or people with sarcopenia. Methods We performed a post hoc sub-study of the Leucine and ACE (LACE) inhibitor trial, which enrolled 145 participants aged �70 years with low grip strength and low gait speed. Partici pants’ blood samples were genotyped for rs179972 using TaqMan and rs5810761 by ampli fication through Hotstar Taq. Genotypes were compared with outcomes of physical performance and body composition measures. Results Data from 136 individuals were included in the analysis. For rs1799722 the genotype fre quency (TT: 17, CC: 48, CT: 71) remained in Hardy-Weinberg Equilibrium (HWE p = 0.248). There was no difference between the genotypes for six-Minute Walk Distance (6MWD) or Short Physical Performance Battery (SPPB). Men with the TT genotype had a significantly greater 6MWD than other genotypes (TT 400m vs CT 310m vs CC 314m, p = 0.027), and greater leg muscle mass (TT 17.59kg vs CT 15.04kg vs CC 15.65kg, p = 0.007). For rs5810761, the genotype frequency (-9-9: 31, +9+9: 43, -9+9: 60) remained in HWE (p = 0.269). The +9+9 genotype was associated with a significant change in SPPB score at 12 months (-9-9 0 vs -9+9 0 vs +9+9–1, p |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
PLoS One; http://hdl.handle.net/10044/1/113768 |
| DOI: |
10.1371/journal.pone.0307268 |
| Availability: |
http://hdl.handle.net/10044/1/113768; https://doi.org/10.1371/journal.pone.0307268 |
| Rights: |
© 2024 Shrestha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ; https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.F4E3F7A4 |
| Database: |
BASE |